Anne M. Connolly

16.9k total citations
132 papers, 4.9k citations indexed

About

Anne M. Connolly is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anne M. Connolly has authored 132 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 43 papers in Genetics and 21 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anne M. Connolly's work include Muscle Physiology and Disorders (58 papers), Neurogenetic and Muscular Disorders Research (41 papers) and Cardiomyopathy and Myosin Studies (13 papers). Anne M. Connolly is often cited by papers focused on Muscle Physiology and Disorders (58 papers), Neurogenetic and Muscular Disorders Research (41 papers) and Cardiomyopathy and Myosin Studies (13 papers). Anne M. Connolly collaborates with scholars based in United States, Australia and United Kingdom. Anne M. Connolly's co-authors include Alan Pestronk, Richard M. Keeling, Craig M. Zaidman, Julaine Florence, Craig M. McDonald, James R. Lupski, Charles F. Towne, Sat Dev Batish, Mehrdad Khajavi and Feng Zhang and has published in prestigious journals such as Circulation, Nature Genetics and PLoS ONE.

In The Last Decade

Anne M. Connolly

131 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne M. Connolly United States 38 2.6k 924 833 747 658 132 4.9k
Isabelle Desguerre France 46 3.6k 1.4× 647 0.7× 1.2k 1.5× 711 1.0× 484 0.7× 212 7.1k
Suely Kazue Nagahashi Marie Brazil 42 3.4k 1.3× 1.3k 1.4× 448 0.5× 839 1.1× 373 0.6× 261 7.0k
Kevin M. Flanigan United States 45 5.6k 2.1× 1.1k 1.2× 1.2k 1.4× 1.2k 1.5× 1.3k 2.0× 189 7.3k
Giuseppe Vita Italy 37 2.5k 1.0× 590 0.6× 289 0.3× 1.1k 1.5× 815 1.2× 245 5.5k
Elena Pegoraro Italy 41 3.8k 1.5× 1.1k 1.2× 476 0.6× 1.6k 2.1× 969 1.5× 196 5.6k
Martin Lammens Netherlands 40 2.0k 0.8× 462 0.5× 528 0.6× 1.0k 1.4× 437 0.7× 191 5.3k
Thomas Voït Germany 40 3.5k 1.3× 982 1.1× 698 0.8× 527 0.7× 1.1k 1.6× 136 5.3k
Francesco Muntoni United Kingdom 50 5.1k 2.0× 1.6k 1.7× 687 0.8× 1.6k 2.1× 1.7k 2.5× 250 7.5k
Emma Ciafaloni United States 35 2.8k 1.1× 766 0.8× 232 0.3× 678 0.9× 599 0.9× 113 4.3k
Christina A. Gurnett United States 44 3.2k 1.2× 561 0.6× 1.5k 1.8× 1.5k 2.0× 771 1.2× 127 6.9k

Countries citing papers authored by Anne M. Connolly

Since Specialization
Citations

This map shows the geographic impact of Anne M. Connolly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne M. Connolly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne M. Connolly more than expected).

Fields of papers citing papers by Anne M. Connolly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne M. Connolly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne M. Connolly. The network helps show where Anne M. Connolly may publish in the future.

Co-authorship network of co-authors of Anne M. Connolly

This figure shows the co-authorship network connecting the top 25 collaborators of Anne M. Connolly. A scholar is included among the top collaborators of Anne M. Connolly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne M. Connolly. Anne M. Connolly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bekircan‐Kurt, Can Ebru, Shoba Subramanian, M. Iammarino, et al.. (2025). Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single‐Center Experience. Muscle & Nerve. 71(3). 414–421. 3 indexed citations
2.
Zaidman, Craig M., Amal Aqul, Russell J. Butterfield, et al.. (2024). Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases. 11(3). 687–699. 9 indexed citations
3.
Servais, Laurent, Lindsey Lair, Anne M. Connolly, et al.. (2024). Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular Atrophy. International Journal of Molecular Sciences. 25(19). 10273–10273. 8 indexed citations
4.
Finkel, Richard S., Basil T. Darras, Jerry R. Mendell, et al.. (2023). Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG). Journal of Neuromuscular Diseases. 10(3). 389–404. 30 indexed citations
5.
Connolly, Anne M., et al.. (2023). Parental Experiences with Newborn Screening and Gene Replacement Therapy for Spinal Muscular Atrophy. Journal of Neuromuscular Diseases. 11(1). 129–142. 3 indexed citations
6.
Clemens, Paula R., Vamshi K. Rao, Anne M. Connolly, et al.. (2022). Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases. 9(4). 493–501. 38 indexed citations
7.
Abdel‐Hamid, Hoda, Barry J. Byrne, Anne M. Connolly, et al.. (2021). A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment. Journal of Neuromuscular Diseases. 9(1). 39–52. 31 indexed citations
8.
Finkel, Richard S., John Day, Basil T. Darras, et al.. (2019). Phase 1 Study of Intrathecal Administration of AVXS-101 Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type 2 (SMA2) (STRONG) (P1.6-059). Neurology. 92(15_supplement). 2 indexed citations
9.
Szabo, Shelagh M., et al.. (2019). PRO65 VARIABILITY IN AGE AT LOSS OF AMBULATION BY GENOTYPE AMONG BOYS WITH DUCHENNE MUSCULAR DYSTROPHY. Value in Health. 22. S853–S853. 1 indexed citations
10.
Glascock, Jacqueline, Jacinda B. Sampson, Amanda Haidet-Phillips, et al.. (2018). Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening. Journal of Neuromuscular Diseases. 5(2). 145–158. 143 indexed citations
11.
Finder, Jonathan D., Oscar H. Mayer, Daniel W. Sheehan, et al.. (2017). Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary. American Journal of Respiratory and Critical Care Medicine. 196(4). 512–519. 33 indexed citations
12.
Sommerville, R. Brian, et al.. (2016). Diagnosis and management of adult hereditary cardio-neuromuscular disorders: A model for the multidisciplinary care of complex genetic disorders. Trends in Cardiovascular Medicine. 27(1). 51–58. 16 indexed citations
13.
Beck, David B., Megan T. Cho, Francisca Millan, et al.. (2016). A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defects. Neurogenetics. 17(3). 173–178. 25 indexed citations
14.
Connolly, Anne M., Julaine Florence, Mary Michaeleen Cradock, et al.. (2014). One Year Outcome of Boys With Duchenne Muscular Dystrophy Using the Bayley-III Scales of Infant and Toddler Development. Pediatric Neurology. 50(6). 557–563. 39 indexed citations
15.
Connolly, Anne M., Kevin Whelan, & Mary Hickson. (2011). Impact of protected mealtimes on mealtime environment and nutrient intake in hospital patients. Journal of Human Nutrition and Dietetics. 24(3). 279–280. 4 indexed citations
16.
Zaidman, Craig M., Anne M. Connolly, Elizabeth C. Malkus, Julaine Florence, & Alan Pestronk. (2010). Quantitative ultrasound using backscatter analysis in Duchenne and Becker muscular dystrophy. Neuromuscular Disorders. 20(12). 805–809. 56 indexed citations
17.
Gurnett, Christina A., Kevin McCall, Sara Miller, et al.. (2010). Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1. Human Molecular Genetics. 19(7). 1165–1173. 86 indexed citations
18.
Escolar, Diana M., Carolina Tesi Rocha, Paula R. Clemens, et al.. (2007). G.P.9.09 Immediate release oral pentoxifylline is poorly tolerated in Duchenne muscular dystrophy boys. Neuromuscular Disorders. 17(9-10). 817–817. 2 indexed citations
19.
Connolly, Anne M., et al.. (2006). Quality of Life of Children With Benign Rolandic Epilepsy. Pediatric Neurology. 35(4). 240–245. 32 indexed citations
20.
Falsaperla, Raffaele, et al.. (2003). Mental Retardation and Early Onset of Weakness in a Girl With a Dystrophinopathy and a Large Xp21-23 Deletion. Journal of Child Neurology. 18(1). 79–81. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Desguerre Breakdown of academic impact, for papers by Suely Kazue Nagahashi Marie Breakdown of academic impact, for papers by Kevin M. Flanigan Breakdown of academic impact, for papers by Giuseppe Vita Breakdown of academic impact, for papers by Elena Pegoraro Breakdown of academic impact, for papers by Martin Lammens Breakdown of academic impact, for papers by Thomas Voït Breakdown of academic impact, for papers by Francesco Muntoni Breakdown of academic impact, for papers by Emma Ciafaloni Breakdown of academic impact, for papers by Christina A. Gurnett
Rankless by CCL
2026